# PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pd-1-pd-l1-checkpoint-inhibitors-in-tumor-immunotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jinhua Liu,Zichao Chen,Yaqun Li,Wenjie Zhao,Jibiao Wu,Zhen Zhang |
| Citations | 423 |
| DOI | 10.3389/fphar.2021.731798 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fphar.2021.731798/pdf |
| OpenAlex ID | https://openalex.org/W3198735776 |
| PMID | 34539412 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Zichao Chen](https://scholariq.org/researchers/zichao-chen/)

## Paper journal

- [Frontiers in Pharmacology](https://scholariq.org/journals/frontiers-in-pharmacology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.